Histone deacetylase inhibitors: from target to clinical trials

Author： Kelly William K O’Connor Owen A Marks Paul A

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.11, Iss.12, 2002-12, pp. : 1695-1713

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone Deacetylase Inhibitors: Current Status and Overview of Recent Clinical Trials

By Xujun Ezzeldin Hany H. Diasio Robert B.

Drugs, Vol. 69, Iss. 14, 2009-10 ,pp. : 1911-1934

Adis International

Access to resources Recommend Favorite

A Review of Depsipeptide and Other Histone Deacetylase Inhibitors in Clinical Trials

Current Pharmaceutical Design, Vol. 10, Iss. 19, 2004-07 ,pp. : 2289-2298

Bentham Science Publishers

Access to resources Recommend Favorite

Histone deacetylase inhibitors in clinical development

By Rosato Roberto R Grant Steven

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 1, 2004-01 ,pp. : 21-38

Informa Healthcare

Access to resources Recommend Favorite

From Discovery to the Coming Generation of Histone Deacetylase Inhibitors

Current Medicinal Chemistry, Vol. 10, Iss. 22, 2003-11 ,pp. : 2351-2358

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple-Target Drugs: Inhibitors of Heat Shock Protein 90 and of Histone Deacetylase

Current Drug Targets, Vol. 6, Iss. 3, 2005-05 ,pp. : 337-351

Bentham Science Publishers

Access to resources Recommend Favorite